MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells

被引:10
|
作者
Jipeng Li
Yulan Song
Yiping Wang
Jianping Luo
Wanjun Yu
机构
[1] Yinzhou People’s Hospital,Department of Clinical Laboratory
[2] Yinzhou People’s Hospital,Department of Nephrology
[3] Yinzhou People’s Hospital,Department of Respiratory Diseases
来源
关键词
miR-148a; Epithelial-to-mesenchymal transition; NSCLC; ROCK1;
D O I
暂无
中图分类号
学科分类号
摘要
Recent studies have implied that miRNAs act as crucial modulators for epithelial-to-mesenchymal transition (EMT). We found that miR-148a is significantly downregulated in non-small cell lung cancer (NSCLC) compared to adjacent non-cancerous lung tissues, and the downregulated miR-148a was significantly associated with lymph-node metastasis. Functional assays demonstrated that miR-148a inhibited EMT in NSCLC cells. Moreover, miR-148a decreased 3′-untranslated region luciferase activity of ROCK1 and ROCK1 protein expression. Knockdown of ROCK1 reversed EMT resembling that of miR-148a overexpression. Furthermore, ROCK1 was widely upregulated in NSCLC, and its mRNA levels were inversely correlated with miR-148a expression. These findings suggest that miR-148a acts as a novel EMT suppressor in NSCLC cells, at least in part by modulation of ROCK1.
引用
收藏
页码:277 / 282
页数:5
相关论文
共 50 条
  • [1] MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells
    Li, Jipeng
    Song, Yulan
    Wang, Yiping
    Luo, Jianping
    Yu, Wanjun
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2013, 380 (1-2) : 277 - 282
  • [2] microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition
    Wang, Sui-Han
    Li, Xu
    Zhou, Li-Sheng
    Cao, Zhong-Wei
    Shi, Chao
    Zhou, Chong-Zhi
    Wen, Yu-Gang
    Shen, Yang
    Li, Ji-Kun
    TUMOR BIOLOGY, 2013, 34 (06) : 3705 - 3712
  • [3] MicroRNA-148a Suppresses Tumor Cell Invasion and Metastasis by Downregulating ROCK1 in Gastric Cancer
    Zheng, Biqiang
    Liang, Linhui
    Wang, Chunmeng
    Huang, Shenglin
    Cao, Xi
    Zha, Ruopeng
    Liu, Li
    Jia, Deshui
    Tian, Qi
    Wu, Jianghong
    Ye, Yanwei
    Wang, Qifeng
    Long, Ziwen
    Zhou, Ye
    Du, Chunyan
    He, Xianghuo
    Shi, Yingqiang
    CLINICAL CANCER RESEARCH, 2011, 17 (24) : 7574 - 7583
  • [4] MicroRNA-148a suppresses the epithelial–mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling
    J-P Zhang
    C Zeng
    L Xu
    J Gong
    J-H Fang
    S-M Zhuang
    Oncogene, 2014, 33 : 4069 - 4076
  • [5] The attenuation of epithelial-to-mesenchymal transition by cypripedin in non-small cell lung cancer cells
    Pongrakhananon, Varisa
    Treesuwan, Surassawadee
    CANCER SCIENCE, 2018, 109 : 1046 - 1046
  • [6] MicroRNA-148b inhibits proliferation and the epithelial-mesenchymal transition and increases radiosensitivity in non-small cell lung carcinomas by regulating ROCK1
    Luo, Haitao
    Liang, Caixia
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (04) : 3609 - 3616
  • [7] MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer
    Kumarswamy, Regalla
    Mudduluru, Giridhar
    Ceppi, Paolo
    Muppala, Santoshi
    Kozlowski, Miroslaw
    Niklinski, Jacek
    Papotti, Mauro
    Allgayer, Heike
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (09) : 2044 - 2053
  • [8] MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling
    Zhang, J-P
    Zeng, C.
    Xu, L.
    Gong, J.
    Fang, J-H
    Zhuang, S-M
    ONCOGENE, 2014, 33 (31) : 4069 - 4076
  • [9] MicroRNA-148a Promotes Myogenic Differentiation by Targeting the ROCK1 Gene
    Zhang, Jing
    Ying, Zheng-zhou
    Tang, Zhong-lin
    Long, Liang-qi
    Li, Kui
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (25) : 21093 - 21101
  • [10] Effect of AXL on the epithelial-to-mesenchymal transition in non-small cell lung cancer
    Ying, Xueming
    Chen, Jun
    Huang, Xueming
    Huang, Peng
    Yan, Shaocong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (01) : 785 - 790